Urticaria
Environmental Dermatology
What’s Eating You? Human Body Lice (Pediculus humanus corporis)
Compared to head and pubic lice, body lice carry increased morbidity in the form of greater body surface area involvement, possible infectious...
Conference Coverage
Rapid improvement seen with nemolizumab for prurigo nodularis in phase 2b study
MADRID – “We saw onset of pruritus improvement in week 1 and onset of lesion healing at week 4.”
Case Letter
Solar Urticaria Treated With Omalizumab
Recurrent solar urticaria can be recalcitrant to treatment. Omalizumab is a viable option to consider in patients with solar urticaria that is...
Latest News
Chronic urticaria population identified
The burden of disease falls much more heavily on women.
Conference Coverage
Ligelizumab maintains urticaria control for up to 1 year
WASHINGTON – The open-label extension trial found a good maintenance of effect in patients with chronic spontaneous urticaria that is...
Conference Coverage
VIDEO: Immunomodulators for inflammatory skin diseases
WASHINGTON - Off-label therapies discussed by Dr. Friedman include dapsone, hydroxychloroquine, and pentoxifylline.
Video
Bedbugs in the Workplace
Bedbug exposures in the workplace are on the rise. Dermatologists and other health care professionals can no longer exclusively associate bedbugs...
Conference Coverage
Choose your steps for treating chronic spontaneous urticaria
CAYMAN ISLANDS – U.S. and European guidelines start with high-dose second-generation antihistamines, but differ in when to introduce other drugs...
Environmental Dermatology
What’s Eating You? Bedbugs
Bedbugs are an increasing problem in the workplace. Employees must be educated on the signs of a bedbug infestation and take preventive measures...
Case Reports
Ice Pack–Induced Perniosis: A Rare and Underrecognized Association
Perniosis, or chilblain, is characterized by skin lesions that occur as an abnormal reaction to exposure to cold and damp conditions. Ice pack–...
Case Letter
Gemcitabine-Induced Pseudocellulitis
Gemcitabine-induced pseudocellulitis is a rare cutaneous side effect of gemcitabine therapy. Early recognition of pseudocellulitis may prevent...